RIDDLE&CODE
2.6.2022 10:17:06 CEST | Business Wire | Press release
RIDDLE&CODE is partnering with Influx Technology LTD to develop the next generation of its Drive&Stake stack. This collaboration focuses on the further evolution of Drive&Stake hardware to transform vehicles into autonomous agents in a new era of mobility.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220602005047/en/
RIDDLE&CODE and Influx Technology are working together to build a powerful and flexible toolchain for original equipment manufacturer (OEM) developers in the automotive ACES (Automated, Connected, Electric and Shared) space to prototype peer-to-peer (P2P) blockchain-based solutions.
With three decades of experience and expertise in developing business-to-business (B2B) automotive embedded systems and deep in-vehicle communication protocol, Influx Technology will help RIDDLE&CODE create the next generation of Drive&Stake hardware.
"The goal is to manufacture a toolchain that reduces complexity and simplifies experimentation, enabling a more significant focus on value-added business models whilst ensuring vehicle safety and security," says Steve Ratheram, Senior R&D Engineer | Automotive Embedded at RIDDLE&CODE.
"Bringing together the automotive industry experience of Influx and the industrial Web3.0 vision of RIDDLE&CODE," says Minh Cao, Director of Mobility at RIDDLE&CODE, "the consortium engineers industry-grade hardware connected to a banking grade distributed ledger technology (DLT) infrastructure that finally transforms any vehicle into an autonomous economic agent and its drivers into data entrepreneurs."
About the Drive&Stake Consortium
The Drive&Stake consortium continues to realise its goal of creating decentralised and secure technologies, focusing on blockchain and cryptography. The D&S stack comprises reference hardware that connects vehicle embedded systems data to a secure exchange-to-exchange (E2E) data & token management system.
In addition to the new hardware, the Drive&Stake Consortium will lead to the following:
- The development of new data economies and vehicle lifecycle revenue streams
- The creation of secure provenance of trustful data
- The development of collaborative and decentralised data-driven business models
- The sharing of data and relevant information between competitors without revealing industry secrets
- Benefit from the network growth through a token-economical business model that governs and grows the network using incentives
- Gain access to the required backend technology stack to enable the rollout of all business processes on the platform in a regulatory compliant way
About RIDDLE&CODE
RIDDLE&CODE is Europe’s leading company for blockchain interface solutions. The company develops hardware and software stacks that combine the security of smart cards with blockchain and the Internet of Things (IoT). Together with its tier-one clients and partners, which include Daimler Mobility, BMW, Wien Energie and leading Dutch crypto exchange LiteBit, RIDDLE&CODE brings new business models to the fintech, energy, mobility and materials industries.
More information: www.riddleandcode.com
About Influx Technology
INFLUX TECHNOLOGY is the leading global name in vehicle CAN bus data logging providing innovative engineering solutions. Our global teams are dedicated to designing modular and flexible solutions that are intuitive to use, manufactured to a high standard with quality post-sale support.
More information: www.influxtechnology.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005047/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom